These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1353691)

  • 41. Optically active benzamides as predictive tools for mapping the dopamine D2 receptor.
    Rognan D; Sokoloff P; Mann A; Martres MP; Schwartz JC; Costentin J; Wermuth CG
    Eur J Pharmacol; 1990 Jul; 189(1):59-70. PubMed ID: 1977603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prandial effect on the systemic exposure of amisulpride.
    Jang YJ; Jeong TC; Noh K; Baek IW; Kwon KI; Kim E; Yoon YR; Kang W
    Arch Pharm Res; 2014 Oct; 37(10):1325-8. PubMed ID: 24469600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Substituted benzamides].
    Scotto JC
    Encephale; 1975; 1(3):223-5. PubMed ID: 6257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose amisulpride and elevation in serum prolactin.
    Andrade C
    J Clin Psychiatry; 2013 Jun; 74(6):e558-60. PubMed ID: 23842026
    [No Abstract]   [Full Text] [Related]  

  • 45. [Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
    Gaĭnetdinov RR; Budygin EA; Kovalev GI; Kudrin VS; Raevskiĭ KS
    Biull Eksp Biol Med; 1992 Jul; 114(7):47-9. PubMed ID: 1358258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats.
    Tanimoto K; Tamminga CA; Chase TN
    Eur J Pharmacol; 1987 Dec; 144(2):147-51. PubMed ID: 3325296
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?
    Baptista T; Parada M; Hernandez L
    Pharmacol Biochem Behav; 1987 Jul; 27(3):399-405. PubMed ID: 2889218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of a novel benzamide, YM-09151-2, on rat serum prolactin levels.
    Meltzer HY; Mikuni M; Simonovic M; Gudelsky GA
    Life Sci; 1983 Feb; 32(9):1015-21. PubMed ID: 6827920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of antiapomorphinic activity of metoclopramide, sulpiride and clebopride in the rat and dog].
    Salazar W; Colombo M; Llupia J; Roberts DJ
    Arch Farmacol Toxicol; 1978 Apr; 4(1):60-3. PubMed ID: 697404
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro transfer of six benzamides in the human placenta.
    Nandakumaran M; Challier JC; Rey E; Richard MO; Olive G
    Dev Pharmacol Ther; 1984; 7 Suppl 1():60-6. PubMed ID: 6518973
    [No Abstract]   [Full Text] [Related]  

  • 51. Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
    Meisenzahl EM; Schmitt G; Gründer G; Dresel S; Frodl T; la Fougère C; Scheuerecker J; Schwarz M; Boerner R; Stauss J; Hahn K; Möller HJ
    Pharmacopsychiatry; 2008 Sep; 41(5):169-75. PubMed ID: 18763218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperprolactinemia after low dose of amisulpride.
    Kopecek M; Bares M; Svarc J; Dockery C; Horácek J
    Neuro Endocrinol Lett; 2004 Dec; 25(6):419-22. PubMed ID: 15665803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Amisulpride, neuroleptic and antinegative action].
    Widlöcher D; Allilaire JF; Guérard des Lauriers A; Lecrubier Y
    Encephale; 1990; 16(2):159-63. PubMed ID: 1972055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
    Kobayashi T; Shimizu H; Toru M
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of amisulpride on consummatory negative contrast.
    Genn RF; Barr AM; Phillips AG
    Behav Pharmacol; 2002 Dec; 13(8):659-62. PubMed ID: 12478217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.